Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CALCRL antagonists(Calcitonin gene-related peptide type 1 receptor antagonists), CGRP antagonists(Calcitonin gene-related peptide antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC35H36N6O5 |
InChIKeyLJMGRDULDLZQAJ-ATKWODBQSA-N |
CAS Registry2568063-73-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Migraine Disorders | Preclinical | GB | 19 Oct 2022 | |
Migraine Disorders | Preclinical | IN | 19 Oct 2022 |